Report Detail
Global Finasteride Tablet Market Insights, Forecast to 2025
- RnM2683456 |
- 12 June, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
The global Finasteride Tablet market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Finasteride Tablet market based on company, product type, end user and key regions.
This report studies the global market size of Finasteride Tablet in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Finasteride Tablet in these regions.
This research report categorizes the global Finasteride Tablet market by top players/brands, region, type and end user. This report also studies the global Finasteride Tablet market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Market size by Product
1mg Tablet
5mg Tablet
Market size by End User
Benign prostatic hyperplasia
Male pattern baldness
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Finasteride Tablet market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Finasteride Tablet market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Finasteride Tablet companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Finasteride Tablet submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Finasteride Tablet are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Finasteride Tablet market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Finasteride Tablet Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Finasteride Tablet Market Size Growth Rate by Product
- 1.4.2 1mg Tablet
- 1.4.3 5mg Tablet
- 1.5 Market by End User
- 1.5.1 Global Finasteride Tablet Market Size Growth Rate by End User
- 1.5.2 Benign prostatic hyperplasia
- 1.5.3 Male pattern baldness
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Finasteride Tablet Market Size
- 2.1.1 Global Finasteride Tablet Revenue 2014-2025
- 2.1.2 Global Finasteride Tablet Sales 2014-2025
- 2.2 Finasteride Tablet Growth Rate by Regions
- 2.2.1 Global Finasteride Tablet Sales by Regions
- 2.2.2 Global Finasteride Tablet Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Finasteride Tablet Sales by Manufacturers
- 3.1.1 Finasteride Tablet Sales by Manufacturers
- 3.1.2 Finasteride Tablet Sales Market Share by Manufacturers
- 3.1.3 Global Finasteride Tablet Market Concentration Ratio (CR5 and HHI)
- 3.2 Finasteride Tablet Revenue by Manufacturers
- 3.2.1 Finasteride Tablet Revenue by Manufacturers (2014-2019)
- 3.2.2 Finasteride Tablet Revenue Share by Manufacturers (2014-2019)
- 3.3 Finasteride Tablet Price by Manufacturers
- 3.4 Finasteride Tablet Manufacturing Base Distribution, Product Types
- 3.4.1 Finasteride Tablet Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Finasteride Tablet Product Type
- 3.4.3 Date of International Manufacturers Enter into Finasteride Tablet Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Finasteride Tablet Sales by Product
- 4.2 Global Finasteride Tablet Revenue by Product
- 4.3 Finasteride Tablet Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Finasteride Tablet Breakdown Data by End User
6 North America
- 6.1 North America Finasteride Tablet by Countries
- 6.1.1 North America Finasteride Tablet Sales by Countries
- 6.1.2 North America Finasteride Tablet Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Finasteride Tablet by Product
- 6.3 North America Finasteride Tablet by End User
7 Europe
- 7.1 Europe Finasteride Tablet by Countries
- 7.1.1 Europe Finasteride Tablet Sales by Countries
- 7.1.2 Europe Finasteride Tablet Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Finasteride Tablet by Product
- 7.3 Europe Finasteride Tablet by End User
8 Asia Pacific
- 8.1 Asia Pacific Finasteride Tablet by Countries
- 8.1.1 Asia Pacific Finasteride Tablet Sales by Countries
- 8.1.2 Asia Pacific Finasteride Tablet Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Finasteride Tablet by Product
- 8.3 Asia Pacific Finasteride Tablet by End User
9 Central & South America
- 9.1 Central & South America Finasteride Tablet by Countries
- 9.1.1 Central & South America Finasteride Tablet Sales by Countries
- 9.1.2 Central & South America Finasteride Tablet Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Finasteride Tablet by Product
- 9.3 Central & South America Finasteride Tablet by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Finasteride Tablet by Countries
- 10.1.1 Middle East and Africa Finasteride Tablet Sales by Countries
- 10.1.2 Middle East and Africa Finasteride Tablet Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Finasteride Tablet by Product
- 10.3 Middle East and Africa Finasteride Tablet by End User
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck Finasteride Tablet Products Offered
- 11.1.5 Merck Recent Development
- 11.2 Actavis
- 11.2.1 Actavis Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Actavis Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Actavis Finasteride Tablet Products Offered
- 11.2.5 Actavis Recent Development
- 11.3 Sandoz
- 11.3.1 Sandoz Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sandoz Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sandoz Finasteride Tablet Products Offered
- 11.3.5 Sandoz Recent Development
- 11.4 Teva Pharmaceuticals
- 11.4.1 Teva Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Teva Pharmaceuticals Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Teva Pharmaceuticals Finasteride Tablet Products Offered
- 11.4.5 Teva Pharmaceuticals Recent Development
- 11.5 Cipla
- 11.5.1 Cipla Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cipla Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cipla Finasteride Tablet Products Offered
- 11.5.5 Cipla Recent Development
- 11.6 RelonChem
- 11.6.1 RelonChem Company Details
- 11.6.2 Company Business Overview
- 11.6.3 RelonChem Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 RelonChem Finasteride Tablet Products Offered
- 11.6.5 RelonChem Recent Development
- 11.7 Dr. Reddy
- 11.7.1 Dr. Reddy Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Dr. Reddy Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Dr. Reddy Finasteride Tablet Products Offered
- 11.7.5 Dr. Reddy Recent Development
- 11.8 Accord Pharmaceuticals
- 11.8.1 Accord Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Accord Pharmaceuticals Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Accord Pharmaceuticals Finasteride Tablet Products Offered
- 11.8.5 Accord Pharmaceuticals Recent Development
- 11.9 Henan Topfond
- 11.9.1 Henan Topfond Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Henan Topfond Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Henan Topfond Finasteride Tablet Products Offered
- 11.9.5 Henan Topfond Recent Development
- 11.10 Zhejiang CONBA Pharmaceutical
- 11.10.1 Zhejiang CONBA Pharmaceutical Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Zhejiang CONBA Pharmaceutical Finasteride Tablet Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Zhejiang CONBA Pharmaceutical Finasteride Tablet Products Offered
- 11.10.5 Zhejiang CONBA Pharmaceutical Recent Development
- 11.11 Shandong Renhetang Pharmaceutical
- 11.12 Guangdong Eashu Pharmacetical
12 Future Forecast
- 12.1 Finasteride Tablet Market Forecast by Regions
- 12.1.1 Global Finasteride Tablet Sales Forecast by Regions 2019-2025
- 12.1.2 Global Finasteride Tablet Revenue Forecast by Regions 2019-2025
- 12.2 Finasteride Tablet Market Forecast by Product
- 12.2.1 Global Finasteride Tablet Sales Forecast by Product 2019-2025
- 12.2.2 Global Finasteride Tablet Revenue Forecast by Product 2019-2025
- 12.3 Finasteride Tablet Market Forecast by End User
- 12.4 North America Finasteride Tablet Forecast
- 12.5 Europe Finasteride Tablet Forecast
- 12.6 Asia Pacific Finasteride Tablet Forecast
- 12.7 Central & South America Finasteride Tablet Forecast
- 12.8 Middle East and Africa Finasteride Tablet Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Finasteride Tablet Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Finasteride Tablet . Industry analysis & Market Report on Finasteride Tablet is a syndicated market report, published as Global Finasteride Tablet Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Finasteride Tablet market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
